Abstract:Abstract Background Serotonin signaling has been associated with tumorigenesis and tumor progression. Targeting the serotonin transporter to block serotonin cellular uptake confers antineoplastic effects in various tumors, including colon cancer. However, the antineoplastic mechanism of serotonin transporter inhibition and serotonin metabolism alterations in the absence of serotonin transporter have not been elucidated, especially in colon cancer, which might limit anti-tumor effects associating with targeting serotonin transporter. Methods The promotion in the uptake and catabolism of extracellular tryptophan and targeting serotonin transporter was detected by using quantitative reverse-transcription polymerase chain reaction, western blotting and liquid chromatography tandem mass spectrometry. Western blotting Immunoprecipitation and immunofluorescence was utilized to research the serotonylation of mTOR by serotonin and serotonin transporter inhibition. The primary mouse model, homograft model and tissue microarry was used to explore the tryptophan pathway in colon cancer. The cell viability assay, western blotting, xenograft and primary colon cancer mouse model were used to identify whether the combination of sertraline and tryptophan restriction had a synergistic effect. Results Targeting serotonin transporter through genetic ablation or pharmacological inhibition in vitro and in vivo induced a compensatory effect by promoting the uptake and catabolism of extracellular tryptophan in colon cancer. Mechanistically, targeting serotonin transporter suppressed mTOR serotonylation, leading to mTOR inactivation and increased tryptophan uptake. In turn, this process promoted serotonin biosynthesis and oncogenic metabolite kynurenine production through enhanced tryptophan catabolism. Tryptophan deprivation, or blocking its uptake by using trametinib, a MEK inhibitor, can sensitize colon cancer to selective serotonin reuptake inhibitors. Conclusions The present study elucidated a novel feedback mechanism involved in the regulation of serotonin homeostasis and suggested innovative strategies for selective serotonin reuptake inhibitors-based treatment of colon cancer.

Serotonin Receptors, Novel Targets Of Sulforaphane Identified By Proteomic Analysis In Caco-2 Cells

Effect of Tbhq and Sulforaphane on Nrf2-ARE Signaling Pathway of Caco2 Cells

Combining network pharmacology and experimental verification to study the anti-colon cancer effect and mechanism of sulforaphene

Sulforaphane-induced Metabolomic Responses with Epigenetic Changes in Estrogen Receptor Positive Breast Cancer Cells

Electrophilic Tuning Of The Chemoprotective Natural Product Sulforaphane

Examination of the differences between sulforaphane and sulforaphene in colon cancer: A study based on next-generation sequencing

Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer Caco-2 cells.

Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review

Pharmacogenomics of Cancer Chemopreventive Isothiocyanate Compound Sulforaphane in the Intestinal Polyps of Apcmin/+ Mice

Effects of sulforaphane on breast cancer based on metabolome and microbiome

Chemopreventive Activity of Sulforaphane

Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment

Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment

Gene Expression Profiles Induced by Cancer Chemopreventive Isothiocyanate Sulforaphane in the Liver of C57bl/6j Mice and C57bl/6j/Nrf2 (-/-) Mice

Sulforaphane Analogues With Heterocyclic Moieties: Syntheses And Inhibitory Activities Against Cancer Cell Lines

Epithelial-mesenchymal Transition, a Novel Target of Sulforaphane Via COX-2/MMP2, 9/snail, ZEB1 and Mir-200C/zeb1 Pathways in Human Bladder Cancer Cells.

Serotonin's Role in Inflammatory Signaling Pathway Modulation for Colon Cancer Suppression

Effects of co-treatment with sulforaphane and autophagy modulators on uridine 5′-diphospho-glucuronosyltransferase 1A isoforms and cytochrome P450 3A4 expression in Caco-2 human colon cancer cells

Sulforaphane Induces Cell Death Through G2/M Phase Arrest and Triggers Apoptosis in HCT 116 Human Colon Cancer Cells

Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines

Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells